Coronavirus disease 2019

Jump to: navigation, search
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).The disease was first identified in 2019 in Wuhan, China, and has since spread globally, resulting in the 2019–20 coronavirus pandemic. Common symptoms include fever, cough and shortness of breath. Muscle pain, sputum production and sore throat are less common. While the majority of cases result in mild symptoms, some progress to severe pneumonia and multi-organ failure.The rate of deaths per number of diagnosed cases is on average 3.4%, ranging from 0.2% in those less than 20 to approximately 15% in those over 80 years old.

The infection is typically spread from one person to another via respiratory droplets produced during coughing and sneezing. Time from exposure to onset of symptoms is generally between two and 14 days, with an average of five days. The standard method of diagnosis is by reverse transcription polymerase chain reaction (rRT-PCR) from a nasopharyngeal swab or throat swab. The infection can also be diagnosed from a combination of symptoms, risk factors and a chest CT scan showing features of pneumonia.

Recommended measures to prevent infection include frequent hand washing, maintaining distance from others, and not touching one's face. The use of masks is recommended for those who suspect they have the virus and their caregivers but not the general public. There is no vaccine or specific antiviral treatment for COVID-19. Management involves treatment of symptoms, supportive care, isolation, and experimental measures.

The World Health Organization (WHO) declared the 2019–20 coronavirus outbreak a pandemic and a Public Health Emergency of International Concern (PHEIC). Evidence of local transmission of the disease has been found in many countries across all six WHO regions


Title Region Description URL Related Pages
Global WHO Now Officially Recommends to Avoid Taking Ibuprofen For COVID-19 Symptoms Covid-ClinicalCovid-Therapeutics
Global COVID-19 Science Report: Therapeutics Covid-Therapeutics
Global Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) Covid-Therapeutics
Global Novel Treatment with Neuroprotective and Antiviral Properties against a Neuroinvasive Human Respiratory Virus - (memantine/Namenda) 2014 Covid-Therapeutics
China Chinese guideline for corona virus treatment and diagnosis (7th edition) Covid-Therapeutics
Global An Effective Treatment for Coronavirus (COVID-19)-Stanford University review of treatments Covid-Therapeutics
Global Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia Covid-Therapeutics
Global Thalidomide Combined with Low-dose Glucocorticoid in the Treatment of COVID-19 Pneumonia Covid-Therapeutics
Global Of Chloroquine and Covid19 (Critical commentary in Antiviral Research, March 5 2020) Covid-Therapeutics
Global Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China Covid-Therapeutics
Global A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 (Journal of Critical Care, March 10, 2020) Covid-Therapeutics
Global Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity Covid-Riskfactor
Global Supporting the Health Care Workforce During the COVID-19 Global Epidemic Covid-Protection
Global 2019-nCoV transmission through the ocular surface must not be ignored--all health care worker require to wear googles Covid-Protection
Global Universal and reusable virus deactivation system for respiratory protection Covid-Protection
Global A Single Ventilator for Multiple Simulated Patients to Meet Disaster Surge
Global European Society of Cardiologists consensus paper on ACEI’s: Stay on your blood pressure medications
Global Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With COVID-19 in Wuhan, China Covid-Risk
Global Co-infection of influenza and coronavirus Covid-Risk
Global Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: Propensity score-based analysis of a before-after cohort study Covid-Therapeutics
Global Head of Bed Elevation or Semirecumbent Positioning Literature Review (is associated with a decreased incidence of aspiration and ventilator-associated pneumonia)
Global Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer Covid-Risk